Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.51 USD | +6.98% | +2.46% | -33.24% |
05-23 | Transcript : Altimmune, Inc. Presents at UBS Obesity Therapeutics Day, May-23-2024 10:00 AM | |
05-09 | Transcript : Altimmune, Inc., Q1 2024 Earnings Call, May 09, 2024 |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
498M | - | |||||
114B | ||||||
105B | ||||||
23.83B | - | |||||
21.73B | - | |||||
18.1B |
- Stock Market
- Equities
- ALT Stock
- Charts Altimmune, Inc.
- Sector Chart